Knowable MagazineA small trial testing the effectiveness of customized mRNA vaccines for treating pancreatic cancer has some promising new results. Seven of the eight people who responded to the treatment are still alive six years later, compared with only two of the eight people who didn’t respond, a team reports at NBC News.
Such customized vaccines, which are engineered to match a person’s specific cancer mutations, are one in a handful of new strategies targeting this difficult-to-treat cancer; learn more from our recent story.
https://knowablemagazine.org/content/article/health-disease/2025/progress-for-pancreatic-cancer
